Many drugs are known to either induce or inhibit the CYP enzymes, thus leading to many different possible drug interactions.
Let's say a patient is taking 2 drugs: A & B. Drug A is metabolized by CYP in the liver, but Drug B is an inhibitor of CYP. The serum levels of Drug A will thus be higher than expected, given the dose, because metabolism is slowed (the enzyme is inhibited, so metabolism is also inhibited), and thus there is a risk of toxicity.
If Drug B were an inducer of CYP enzymes, then serum levels of Drug A would probably be sub-therapeutic (metabolism is stimulated/sped up due to enzyme induction.)
Not sure if this helps, hope it does.